Signing Fee. Novo Nordisk shall pay to Zosano a non-refundable, non-creditable license fee of USD one million (USD 1,000,000) within ten (10) business days after the Effective Date.
Appears in 3 contracts
Sources: Licensing Agreement, Licensing Agreement, Collaboration, Development and License Agreement (Zosano Pharma Corp)